Terbium-sensitized luminescence determination of levofloxacin in tablets and human urine and serum.
A selective and sensitive luminescence method for the determination of levofloxacin is described. The method is based in the luminescence signal from a terbium(III)-levofloxacin complex, in a micellar solution of sodium dodecyl sulfate (SDS), using a chemical deoxygenation agent (Na2SO3). The method allows the determination of 8-600 ng mL-1 of levofloxacin in 10 mM SDS solution containing 0.04 M acetic acid-sodium acetate buffer (pH 6) and 7.5 mM Na2SO3 with lambda exc = 292 nm and lambda em = 546 nm. The luminescence method was applied to the determination of the levofloxacin in a Spanish commercialized pharmaceutical formulation Tavanic (Hoechst Marion Roussel). Good concordance was found between the nominal and experimental values (500 and 488 mg, respectively), with a relative standard deviation (RSD) of 0.6%. The proposed method was shown to be 100-fold more sensitive than the spectrophotometric method, and nearly 2-fold more sensitive than the fluorescence method. The method was also applied to levofloxacin determination in human serum (by external calibration method) and urine (by standard additions method), spiked at levels found after drug administration at normal clinical doses. Average recoveries found were 90.1 (RSD 1%) and 102 (RSD 1.9%), respectively.
Ocaña
J A
JA
Department of Analytical Chemistry, Faculty of Chemistry, Seville, Spain.
Callejón
M
M
Barragán
F J
FJ
D000890:Anti-Infective Agents / Q000032:analysis* / Q000097:blood / Q000652:urine; D006801:Humans; D064704:Levofloxacin; D049449:Luminescence; D015242:Ofloxacin / Q000032:analysis* / Q000097:blood / Q000652:urine; D013607:Tablets; D013725:Terbium
D000890:Anti-Infective Agents; D013607:Tablets; D013725:Terbium; D064704:Levofloxacin; D015242:Ofloxacin